EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics

Sophie Helaine, Brian P Conlon, Kimberly M Davis, David G Russell

Cell Host & Microbe · 2024-06 · 32 (6) · 852-862

DOI: 10.1016/j.chom.2024.04.019 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2024-06. Verfasst von Sophie Helaine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Harvard Medical School, Boston, MA, USA. Electronic address: sophie_helaine@hms.harvard.edu. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, Burroughs Wellcome Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance, typically associated with genetic changes within a bacterial population, is a frequent contributor to antibiotic treatment failures. Antibiotic persistence and tolerance, which we collectively term recalcitrance, represent transient phenotypic changes in the bacterial population that prolong survival in the presence of typically lethal concentrations of antibiotics. Antibiotic recalcitrance is challenging to detect and investigate-traditionally studied under in vitro conditions, our understanding during infection and its contribution to antibiotic failure is limited. Recently, significant progress has been made in the study of antibiotic-recalcitrant populations in pathogenic species, including Mycobacterium tuberculosis, Staphylococcus aureus, Salmonella enterica, and Yersiniae, in the context of the host environment. Despite the diversity of these pathogens and infection models, shared signals and responses promote recalcitrance, and common features and vulnerabilities of persisters and tolerant bacteria have emerged. These will be discussed here, along with progress toward developing therapeutic interventions to better treat recalcitrant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBacteriaHumansAnimalsHost-Pathogen InteractionsStress, PhysiologicalDrug Resistance, BacterialBacterial InfectionsMycobacterium tuberculosisStaphylococcus aureus

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Harvard Medical School, Boston, MA, USA. Electronic address: sophie_helaine@hms.harvard.edu.
  • Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. Electronic address: brian_conlon@med.unc.edu.
  • W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: kdavi140@jhu.edu.
  • Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. Electronic address: dgr8@cornell.edu.

Förderung

  • NIAID NIH HHS
  • National Institutes of Health
  • Burroughs Wellcome Fund

Zitieren

APA

Helaine, S., Conlon, B. P., Davis, K. M., & Russell, D. G. (2024). Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics. Cell Host & Microbe, 32(6), 852-862. https://doi.org/10.1016/j.chom.2024.04.019

Vancouver

Helaine S, Conlon BP, Davis KM, Russell DG. Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics. Cell Host & Microbe. 2024;32(6):852-862. doi:10.1016/j.chom.2024.04.019

BibTeX
@article{Helaine2024,
  author = {Helaine, Sophie and Conlon, Brian P and Davis, Kimberly M and Russell, David G},
  title = {Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics},
  journal = {Cell Host & Microbe},
  year = {2024},
  volume = {32},
  number = {6},
  pages = {852--862},
  doi = {10.1016/j.chom.2024.04.019}
}
Kostenlos starten →